Skip to main content

Boston Scientific Emerging Markets revenue

  • BSX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$44.34+0.32%Close 13 Nov 2026 · Market value $63.59B

Emerging Markets revenue at Boston Scientific came to $771.0M for the quarter to 31 Dec 2025, up 15.4% from a year earlier.

As Boston Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 17 Feb 2026.

By quarter

$529.0MMar 2023$592.0MJun 2023$594.0MSep 2023$595.0MDec 2023$648.0MMar 2024$680.0MJun 2024$684.0MSep 2024$668.0MDec 2024$690.0MMar 2025$758.0MJun 2025$765.0MSep 2025$771.0MDec 2025
Boston Scientific Emerging Markets revenue, every reported period
Period endingEmerging Markets revenueChange on a yearFiled
31 Dec 2025$771.0Mup 15.4%17 Feb 2026
30 Sep 2025$765.0Mup 11.8%3 Nov 2025
30 Jun 2025$758.0Mup 11.5%1 Aug 2025
31 Mar 2025$690.0Mup 6.5%1 May 2025
31 Dec 2024$668.0Mup 12.3%18 Feb 2025
30 Sep 2024$684.0Mup 15.2%1 Nov 2024
30 Jun 2024$680.0Mup 14.9%1 Aug 2024
31 Mar 2024$648.0Mup 22.5%1 May 2024
31 Dec 2023$595.0Mup 16.4%20 Feb 2024
30 Sep 2023$594.0Mup 14.5%1 Nov 2023
30 Jun 2023$592.0Mup 18.9%3 Aug 2023
31 Mar 2023$529.0Mup 20.2%4 May 2023
31 Dec 2022$511.0Mup 28.4%23 Feb 2023
30 Sep 2022$519.0Mup 46.6%3 Nov 2022
30 Jun 2022$498.0Mup 38.7%4 Aug 2022
31 Mar 2022$440.0Mup 38.8%5 May 2022
31 Dec 2021$398.0Mup 30.1%23 Feb 2022
30 Sep 2021$354.0Mup 21.6%4 Nov 2021
30 Jun 2021$359.0Mup 34.0%6 Aug 2021
31 Mar 2021$317.0Mup 16.1%6 May 2021
31 Dec 2020$306.0Mdown 6.4%23 Feb 2021
30 Sep 2020$291.0Mdown 6.1%5 Nov 2020
30 Jun 2020$268.0Mdown 15.7%5 Aug 2020
31 Mar 2020$273.0Mdown 8.1%6 May 2020
31 Dec 2019$327.0Mup 14.7%25 Feb 2020
30 Sep 2019$310.0Mup 16.1%5 Nov 2019
30 Jun 2019$318.0Mup 12.4%30 Jul 2019
31 Mar 2019$297.0Mup 13.4%29 Apr 2019
31 Dec 2018$285.0Mup 19.7%19 Feb 2019
30 Sep 2018$267.0Mup 13.1%29 Oct 2018
30 Jun 2018$283.0Mup 25.2%31 Jul 2018
31 Mar 2018$262.0Mup 26.0%1 May 2018
31 Dec 2017$238.0M—20 Feb 2018
30 Sep 2017$236.0M—2 Nov 2017
30 Jun 2017$226.0M—3 Aug 2017
31 Mar 2017$208.0M—3 May 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Boston Scientific: Interventional Cardiology & Vascular Therapies revenue · Electrophysiology revenue · Endoscopy revenue · Peripheral Interventions revenue · Urology revenue · Cardiac Rhythm Management revenue · Watchman revenue · Neuromodulation revenue · Interventional Oncology & Embolization revenue · Cardiology revenue · Cardiovascular revenue · MedSurg revenue · United States revenue · Int'l revenue · financial statements

Every KPI and segment of BSX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.